Skip to content
naulon
Not checkedNot checked for notices yet.

Vancomycin-Resistant Staphylococcus aureus isolates among hospitalized patients; a tertiary medical care center experience from Southern Iran

Farhad Sarrafzadeh, Zienab Mirzabiegi, Mohammad Torabi-Nami

Cogent Medicine · 2016

doi:10.1080/2331205x.2016.1163768 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background and Objective: Bacterial resistance to different types of antibiotics has been globally emerging over recent years. The present study was carried out to investigate the rate of vancomycin-resistant Staphylococcus aureus (VRSA) at a tertiary medical care center in Kerman, Iran. Materials and Methods: In this cross-sectional study, 250 samples with positive culture for coagulase-positive S. aureus, taken from the suspected infectious sites of patients admitted to different medical and surgical wards at Bahonar hospital from 2009 to 2011, were studied. Results: 9.2% of S. aureus isolates were found to be vancomycin-resistant. There was no significant difference in the rate of resistance between males and females (8 vs. 12.9%, respectively). Though the rate of resistance was shown to be marginally higher in post-surgical compared to medical ward patients, the difference was statistically insignificant (p = 0.8). Across the wards, general surgery housed the largest number of patients with VRSA (20%). Conclusion: The emergence of VRSA isolates has perhaps not received a great deal of attention so far. It appears that the increasing use of vancomycin in non-complicated infections may contribute to the emergence of S. aureus isolates which turn to be vancomycin-resistant.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.